Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Monit Comput ; 33(6): 1033-1041, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30603824

RESUMO

The multiple inert gas elimination technique (MIGET) using gas chromatography (GC) is an established but time-consuming method of determining ventilation/perfusion (VA/Q) distributions. MIGET-when performed using Micropore Membrane Inlet Mass Spectrometry (MMIMS)-has been proven to correlate well with GC-MIGET and reduces analysis time substantially. We aimed at comparing shunt fractions and dead space derived from MMIMS-MIGET with Riley shunt and Bohr dead space, respectively. Thirty anesthetized pigs were randomly assigned to lavage or pulmonary embolism groups. Inert gas infusion (saline mixture of SF6, krypton, desflurane, enflurane, diethyl ether, acetone) was maintained, and after induction of lung damage, blood and breath samples were taken at 15-min intervals over 4 h. The samples were injected into the MMIMS, and resultant retention and excretion data were translated to VA/Q distributions. We compared MMIMS-derived shunt (MM-S) to Riley shunt, and MMIMS-derived dead space (MM-VD) to Bohr dead space in 349 data pairs. MM-S was on average lower than Riley shunt (- 0.05 ± 0.10), with lower and upper limits of agreement of - 0.15 and 0.04, respectively. MM-VD was on average lower than Bohr dead space (- 0.09 ± 0.14), with lower and upper limits of agreement of - 0.24 and 0.05. MM-S and MM-VD correlated and agreed well with Riley shunt and with Bohr dead space. MM-S increased significantly after lung injury only in the lavage group, whereas MM-VD increased significantly in both groups. This is the first work evaluating and demonstrating the feasibility of near real-time VA/Q distribution measurements with the MIGET and the MMIMS methods.


Assuntos
Lesão Pulmonar/fisiopatologia , Pulmão/cirurgia , Embolia Pulmonar/fisiopatologia , Espaço Morto Respiratório , Anestesia Geral , Animais , Gasometria , Cromatografia Gasosa , Gases , Hemodinâmica , Lesão Pulmonar/cirurgia , Espectrometria de Massas , Filtros Microporos , Propofol/administração & dosagem , Embolia Pulmonar/cirurgia , Suínos , Relação Ventilação-Perfusão
2.
Vet Pathol ; 52(6): 1172-5, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-25516065

RESUMO

Suspected Streptomyces spp infections were identified in 4 cats at UC Davis Veterinary Medical Teaching Hospital between 1982 and 2011. Three had ulcerated, dark red mycetomas involving the dermis, subcutis, and fascia with fistulous tracts and/or regional lymphadenopathy. One cat had pyogranulomatous mesenteric lymphadenitis. Granulomatous inflammation in all cats contained colonies of Gram-positive, non-acid-fast organisms. All 4 cats failed to respond to aggressive medical and surgical treatment and were euthanized. Laser capture microdissection (LCM) was used to selectively harvest DNA from the affected formalin-fixed, paraffin-embedded (FFPE) tissues. Cloned amplicons from LCM-derived tissue confirmed the presence of Streptomyces spp in the dermatitis cases. Amplicons from the remaining cat with peritoneal involvement aligned with the 16S ribosomal RNA gene for Actinomycetales. Usually considered a contaminant, Streptomyces spp can be associated with refractory pyogranulomatous dermatitis and cellulitis in cats with outdoor access. LCM is useful in the diagnosis of bacterial diseases where contamination may be an issue.


Assuntos
Doenças do Gato/microbiologia , Celulite (Flegmão)/veterinária , Dermatite/veterinária , Microdissecção e Captura a Laser/veterinária , Streptomyces/isolamento & purificação , Animais , Sequência de Bases , Doenças do Gato/patologia , Gatos , Celulite (Flegmão)/microbiologia , Celulite (Flegmão)/patologia , DNA Bacteriano/química , DNA Bacteriano/genética , Dermatite/microbiologia , Dermatite/patologia , Feminino , Masculino , Dados de Sequência Molecular , Inclusão em Parafina/veterinária , RNA Ribossômico 16S/química , RNA Ribossômico 16S/genética , Análise de Sequência de DNA/veterinária , Streptomyces/genética
3.
Br J Cancer ; 102(10): 1511-8, 2010 May 11.
Artigo em Inglês | MEDLINE | ID: mdl-20461094

RESUMO

BACKGROUND: About 1-5% of cancer patients suffer from significant normal tissue reactions as a result of radiotherapy (RT). It is not possible at this time to predict how most patients' normal tissues will respond to RT. DNA repair dysfunction is implicated in sensitivity to RT particularly in genes that mediate the repair of DNA double-strand breaks (DSBs). Phosphorylation of histone H2AX (phosphorylated molecules are known as gammaH2AX) occurs rapidly in response to DNA DSBs, and, among its other roles, contributes to repair protein recruitment to these damaged sites. Mammalian cell lines have also been crucial in facilitating the successful cloning of many DNA DSB repair genes; yet, very few mutant cell lines exist for non-syndromic clinical radiosensitivity (RS). METHODS: Here, we survey DNA DSB induction and repair in whole cells from RS patients, as revealed by gammaH2AX foci assays, as potential predictive markers of clinical radiation response. RESULTS: With one exception, both DNA focus induction and repair in cell lines from RS patients were comparable with controls. Using gammaH2AX foci assays, we identified a RS cancer patient cell line with a novel ionising radiation-induced DNA DSB repair defect; these data were confirmed by an independent DNA DSB repair assay. CONCLUSION: gammaH2AX focus measurement has limited scope as a pre-RT predictive assay in lymphoblast cell lines from RT patients; however, the assay can successfully identify novel DNA DSB repair-defective patient cell lines, thus potentially facilitating the discovery of novel constitutional contributions to clinical RS.


Assuntos
Quebras de DNA de Cadeia Dupla/efeitos da radiação , DNA/metabolismo , Técnicas Genéticas , Histonas/efeitos da radiação , Neoplasias/genética , Tolerância a Radiação/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/genética , Linhagem Celular Tumoral , Reparo do DNA , Feminino , Imunofluorescência , Histonas/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/radioterapia , Fenótipo , Fosforilação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA